Figure 1.
Single-agent activity of carfilzomib in patients who have received one to three prior therapies. Overall response rates are shown along with responses in bortezomib-exposed and bortezomib-naïve patients.
Single-agent activity of carfilzomib in patients who have received one to three prior therapies. Overall response rates are shown along with responses in bortezomib-exposed and bortezomib-naïve patients.
